Erts Wealth Advisors, LLC Johnson & Johnson Transaction History

Erts Wealth Advisors, LLC

$497 Million
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 17, 2023	SELL	$154.35 - $166.11 $1,389 - $1,494	-9 Reduced 0.28%	3,263 $540,000
Q1 2023 Apr 18, 2023	SELL	$151.05 - $180.26 $88,968 - $106,173	-589 Reduced 15.26%	3,272 $507,000
Q4 2022 Jan 27, 2023	SELL	$160.2 - $179.79 $3,684 - $4,135	-23 Reduced 0.59%	3,861 $682,000
Q3 2022 Nov 08, 2022	SELL	$161.33 - $179.52 $5,969 - $6,642	-37 Reduced 0.94%	3,884 $634,000
Q2 2022 Aug 08, 2022	SELL	$168.19 - $186.01 $10,764 - $11,904	-64 Reduced 1.61%	3,921 $696,000
Q1 2022 May 11, 2022	SELL	$158.14 - $179.59 $92,670 - $105,239	-586 Reduced 12.82%	3,985 $706,000
Q4 2021 Feb 15, 2022	BUY	$155.93 - $173.01 $3,274 - $3,633	21 Added 0.46%	4,571 $781,000
Q2 2021 Aug 11, 2021	SELL	$159.48 - $171.07 $478 - $513	-3 Reduced 0.07%	4,550 $750,000
Q1 2021 May 07, 2021	BUY	$153.07 - $170.48 $79,137 - $88,138	517 Added 12.81%	4,553 $748,000
Q4 2020 Feb 12, 2021	SELL	$137.11 - $157.38 $2,193 - $2,518	-16 Reduced 0.39%	4,036 $635,000
Q3 2020 Nov 13, 2020	SELL	$140.38 - $153.83 $14,739 - $16,152	-105 Reduced 2.53%	4,052 $603,000
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $5,667 - $6,842	44 Added 1.07%	4,157 $585,000
Q1 2020 May 15, 2020	BUY	$111.14 - $153.99 $202,830 - $281,031	1,825 Added 79.76%	4,113 $539,000
Q4 2019 Feb 19, 2020	BUY	$127.5 - $146.44 $171,105 - $196,522	1,342 Added 141.86%	2,288 $334,000
Q4 2019 Feb 12, 2020	SELL	$127.5 - $146.44 $171,105 - $196,522	-1,342 Reduced 58.65%	946 $122,000
Q3 2019 Nov 05, 2019	BUY	$126.95 - $142.14 $170,366 - $190,751	1,342 Added 141.86%	2,288 $296,000
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $116,206 - $139,856	946 New	946 $122,000

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Erts Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Erts Wealth Advisors, LLC with notifications on news.

Account